This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugg, S. L. Articles by Asa, S. L. Search for Related Content PubMed PubMed Citation Articles by Sugg, S. L. Articles by Asa, S. L.

Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia¹

Departments of Pathology and Laboratory Medicine, Surgery, Medicine, and Otolaryngology, Mount Sinai Hospital and the University of Toronto, Toronto, Ontario, Canada M5G 1X5

Address all correspondence and requests for reprints to: Sylvia L. Asa, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5 Canada. E-mail: sasa{at}mtsinai.on.ca

Rearrangements involving the RET protooncogene have been implicated in the development of papillary thyroid carcinoma (PC). Transgenic mice, expressing thyroid-targeted RET/PTC-1, develop PC; but the clinical significance of this oncogene remains uncertain. We examined the expression of RET/PTC-1, -2, and -3 in human thyroid microcarcinomas and clinically evident PC to determine its role in early stage vs. developed PC and to examine the diversity of RET/PTC in multifocal disease. RNA was extracted from paraffin-embedded microcarcinomas and clinically evident PCs; the results obtained from paraffin-embedded tissue were confirmed on RNA from corresponding snap-frozen tissue of clinically evident PCs. RT and PCR was performed using primers for RET/PTC-1, -2, and -3; PGK-1 (the housekeeping gene) analysis was used to ensure integrity of the RNA and efficiency of the RT reaction. PCR products were resolved by gel electrophoresis, and Southern hybridization was performed with RET/PTC-1, -2, and -3 probes. A polyclonal antibody to the carboxyterminus of RET was used for immunohistochemistry on paraffin sections. Thirty-nine occult papillary thyroid microcarcinomas from 21 patients were analyzed. Of the 30 tumors (77%) positive for RET/PTC rearrangements, 12 were positive for RET/PTC-1, 3 for RET/PTC-2, 6 for RET/PTC-3, and 9 for multiple RET/PTC oncogenes. In clinically evident tumors, 47% had RET/PTC rearrangements. Immunohistochemistry demonstrated close correlation with RT-PCR-derived findings. RET/PTC expression is highly prevalent in microcarcinoma and occurs more frequently than in clinically evident PC (P < 0.005). Multifocal disease, identified in 17 of the 21 patients, exhibited identical RET/PTC rearrangements within multiple tumors in only 2 patients; the other 15 patients had diverse rearrangements in individual tumors. Our results indicate that RET/PTC oncogene rearrangements may play a role in early-stage papillary thyroid carcinogenesis, but they seem to be less important in determining progression to clinically-evident disease. In multifocal disease, the diversity of RET/PTC profiles, in the majority of cases, suggests that individual tumors arise independently in a background of genetic or environmental susceptibility.

This article has been cited by other articles:

				X. Lin, S. D Finkelstein, B. Zhu, and J. F Silverman Molecular analysis of multifocal papillary thyroid carcinoma J. Mol. Endocrinol., October 1, 2008; 41(4): 195 - 203. [Abstract] [Full Text] [PDF]

				G. Riesco-Eizaguirre and P. Santisteban New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy Endocr. Relat. Cancer, December 1, 2007; 14(4): 957 - 977. [Abstract] [Full Text] [PDF]

				R. Giannini, C. Ugolini, C. Lupi, A. Proietti, R. Elisei, G. Salvatore, P. Berti, G. Materazzi, P. Miccoli, M. Santoro, et al. The Heterogeneous Distribution of BRAF Mutation Supports the Independent Clonal Origin of Distinct Tumor Foci in Multifocal Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3511 - 3516. [Abstract] [Full Text] [PDF]

				M. Santoro, R. M. Melillo, and A. Fusco RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur. J. Endocrinol., November 1, 2006; 155(5): 645 - 653. [Abstract] [Full Text] [PDF]

				Z. Zhu, R. Ciampi, M. N. Nikiforova, M. Gandhi, and Y. E. Nikiforov Prevalence of RET/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3603 - 3610. [Abstract] [Full Text] [PDF]

				J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors Endocr. Rev., August 1, 2006; 27(5): 535 - 560. [Abstract] [Full Text] [PDF]

				E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M. R. Ambrosio, L. Busutti, E. N. Pearce, L. E. Braverman, and E. C. degli Uberti Clinical and Histological Characteristics of Papillary Thyroid Microcarcinoma: Results of a Retrospective Study in 243 Patients J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2171 - 2178. [Abstract] [Full Text] [PDF]

				K. J. Rhoden, K. Unger, G. Salvatore, Y. Yilmaz, V. Vovk, G. Chiappetta, M. B. Qumsiyeh, J. L. Rothstein, A. Fusco, M. Santoro, et al. RET/Papillary Thyroid Cancer Rearrangement in Nonneoplastic Thyrocytes: Follicular Cells of Hashimoto's Thyroiditis Share Low-Level Recombination Events with a Subset of Papillary Carcinoma J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2414 - 2423. [Abstract] [Full Text] [PDF]

				B Jarzab, D Handkiewicz-Junak, and J Wloch Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review Endocr. Relat. Cancer, December 1, 2005; 12(4): 773 - 803. [Abstract] [Full Text] [PDF]

				T. M. Shattuck, W. H. Westra, P. W. Ladenson, and A. Arnold Independent Clonal Origins of Distinct Tumor Foci in Multifocal Papillary Thyroid Carcinoma N. Engl. J. Med., June 9, 2005; 352(23): 2406 - 2412. [Abstract] [Full Text] [PDF]

				E Puxeddu, J A Knauf, M A Sartor, N Mitsutake, E P Smith, M Medvedovic, C R Tomlinson, S Moretti, and J A Fagin RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response Endocr. Relat. Cancer, June 1, 2005; 12(2): 319 - 334. [Abstract] [Full Text] [PDF]

				J A Fagin How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy J. Endocrinol., November 1, 2004; 183(2): 249 - 256. [Abstract] [Full Text] [PDF]

				J. A. Fagin Challenging Dogma in Thyroid Cancer Molecular Genetics--Role of RET/PTC and BRAF in Tumor Initiation J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4264 - 4266. [Full Text] [PDF]

				K. Unger, H. Zitzelsberger, G. Salvatore, M. Santoro, T. Bogdanova, H. Braselmann, P. Kastner, L. Zurnadzhy, N. Tronko, P. Hutzler, et al. Heterogeneity in the Distribution of RET/PTC Rearrangements within Individual Post-Chernobyl Papillary Thyroid Carcinomas J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4272 - 4279. [Abstract] [Full Text] [PDF]

				S L Asa My approach to oncocytic tumours of the thyroid J. Clin. Pathol., March 1, 2004; 57(3): 225 - 232. [Abstract] [Full Text] [PDF]

				E. Puxeddu, N. Mitsutake, J. A. Knauf, S. Moretti, H. W. Kim, K. A. Seta, D. Brockman, L. Myatt, D. E. Millhorn, and J. A. Fagin Microsomal Prostaglandin E2 Synthase-1 Is Induced by Conditional Expression of RET/PTC in Thyroid PCCL3 Cells through the Activation of the MEK-ERK Pathway J. Biol. Chem., December 26, 2003; 278(52): 52131 - 52138. [Abstract] [Full Text] [PDF]

				X. Xu, R. M. Quiros, P. Gattuso, K. B. Ain, and R. A. Prinz High Prevalence of BRAF Gene Mutation in Papillary Thyroid Carcinomas and Thyroid Tumor Cell Lines Cancer Res., August 1, 2003; 63(15): 4561 - 4567. [Abstract] [Full Text] [PDF]

				J. Wang, J. A. Knauf, S. Basu, E. Puxeddu, H. Kuroda, M. Santoro, A. Fusco, and J. A. Fagin Conditional Expression of RET/PTC Induces a Weak Oncogenic Drive in Thyroid PCCL3 Cells and Inhibits Thyrotropin Action at Multiple Levels Mol. Endocrinol., July 1, 2003; 17(7): 1425 - 1436. [Abstract] [Full Text] [PDF]

				K. Boelaert, C. J. McCabe, L. A. Tannahill, N. J. L. Gittoes, R. L. Holder, J. C. Watkinson, A. R. Bradwell, M. C. Sheppard, and J. A. Franklyn Pituitary Tumor Transforming Gene and Fibroblast Growth Factor-2 Expression: Potential Prognostic Indicators in Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2341 - 2347. [Abstract] [Full Text] [PDF]

				C. A. French, E. K. Alexander, E. S. Cibas, V. Nose, J. Laguette, W. Faquin, J. Garber, F. Moore Jr, J. A. Fletcher, P. R. Larsen, et al. Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer Am. J. Pathol., April 1, 2003; 162(4): 1053 - 1060. [Abstract] [Full Text] [PDF]

				S. P. Finn, P. Smyth, J. O'Leary, E. C. Sweeney, and O. Sheils Ret/PTC Chimeric Transcripts in an Irish Cohort of Sporadic Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 938 - 941. [Abstract] [Full Text] [PDF]

				M. D. Ringel and M. A. Levine Current Therapy for Childhood Thyroid Cancer: Optimal Surgery and the Legacy of King Pyrrhus Ann. Surg. Oncol., January 1, 2003; 10(1): 4 - 6. [Full Text] [PDF]

				A. R. Marques, C. Espadinha, A. L. Catarino, S. Moniz, T. Pereira, L. G. Sobrinho, and V. Leite Expression of PAX8-PPAR{gamma}1 Rearrangements in Both Follicular Thyroid Carcinomas and Adenomas J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3947 - 3952. [Abstract] [Full Text] [PDF]

				J. A. Fagin Perspective: Lessons Learned from Molecular Genetic Studies of Thyroid Cancer--Insights into Pathogenesis and Tumor-Specific Therapeutic Targets Endocrinology, June 1, 2002; 143(6): 2025 - 2028. [Full Text] [PDF]

				T. G. Kroll Molecular Rearrangements and Morphology in Thyroid Cancer Am. J. Pathol., June 1, 2002; 160(6): 1941 - 1944. [Full Text] [PDF]

				A. Fusco, G. Chiappetta, P. Hui, G. Garcia-Rostan, L. Golden, B. K. Kinder, D. A. Dillon, A. Giuliano, A. M. Cirafici, M. Santoro, et al. Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma : A Search for the Early Precursors of Papillary Cancer Am. J. Pathol., June 1, 2002; 160(6): 2157 - 2167. [Abstract] [Full Text] [PDF]

				E. L. Mazzaferri and R. T. Kloos Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation? J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1490 - 1498. [Abstract] [Full Text] [PDF]

				M. L. C. Khoo, N. J. P. Beasley, S. Ezzat, J. L. Freeman, and S. L. Asa Overexpression of Cyclin D1 and Underexpression of p27 Predict Lymph Node Metastases in Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1814 - 1818. [Abstract] [Full Text] [PDF]

				G. Belchetz, C. C. Cheung, J. Freeman, I. B. Rosen, I. J. Witterick, and S. L. Asa Hurthle Cell Tumors: Using Molecular Techniques to Define a Novel Classification System Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 237 - 240. [Abstract] [Full Text] [PDF]

				M. L. C. Khoo, J. L. Freeman, I. J. Witterick, J. C. Irish, L. E. Rotstein, P. J. Gullane, and S. L. Asa Underexpression of p27/Kip in Thyroid Papillary Microcarcinomas With Gross Metastatic Disease Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 253 - 257. [Abstract] [Full Text] [PDF]

				M. Santoro, M. Papotti, G. Chiappetta, G. Garcia-Rostan, M. Volante, C. Johnson, R. L. Camp, F. Pentimalli, C. Monaco, A. Herrero, et al. RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 370 - 379. [Abstract] [Full Text] [PDF]

				R. Elisei, C. Romei, T. Vorontsova, B. Cosci, V. Veremeychik, E. Kuchinskaya, F. Basolo, E. P. Demidchik, P. Miccoli, A. Pinchera, et al. RET/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3211 - 3216. [Abstract] [Full Text] [PDF]

				K M Ropponen, J K Kellokoski, R T Pirinen, K I Moisio, M J Eskelinen, E M Alhava, and V-M Kosma Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation J. Clin. Pathol., July 1, 2001; 54(7): 533 - 538. [Abstract] [Full Text] [PDF]

				C. C. Cheung, B. Carydis, S. Ezzat, Y. C. Bedard, and S. L. Asa Analysis of ret/PTC Gene Rearrangements Refines the Fine Needle Aspiration Diagnosis of Thyroid Cancer J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2187 - 2190. [Abstract] [Full Text]

				E. L. Mazzaferri and R. T. Kloos Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1447 - 1463. [Full Text]

				E. L. Chua, W. M. Wu, K. T. Tran, S. W. McCarthy, C. S. Lauer, D. Dubourdieu, N. Packham, C. J. O’Brien, J. R. Turtle, and Q. Dong Prevalence and Distribution of ret/ptc 1, 2, and 3 in Papillary Thyroid Carcinoma in New Caledonia and Australia J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2733 - 2739. [Abstract] [Full Text]

				C. L. Fenton, Y. Lukes, D. Nicholson, C. A. Dinauer, G. L. Francis, and R. M. Tuttle The ret/PTC Mutations Are Common in Sporadic Papillary Thyroid Carcinoma of Children and Young Adults J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1170 - 1175. [Abstract] [Full Text]

				C. C. Cheung, S. Ezzat, L. Ramyar, J. L. Freeman, and S. L. Asa Molecular Basis of Hurthle Cell Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 878 - 882. [Abstract] [Full Text]

				G. A. Thomas, H. Bunnell, H. A. Cook, E. D. Williams, A. Nerovnya, E. D. Cherstvoy, N. D. Tronko, T. I. Bogdanova, G. Chiappetta, G. Viglietto, et al. High Prevalence of RET/PTC Rearrangements in Ukrainian and Belarussian Post-Chernobyl Thyroid Papillary Carcinomas: A Strong Correlation between RET/PTC3 and the Solid-Follicular Variant J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4232 - 4238. [Abstract] [Full Text]

				C. Soravia, S. L. Sugg, T. Berk, A. Mitri, H. Cheng, S. Gallinger, Z. Cohen, S. L. Asa, and B. V. Bapat Familial Adenomatous Polyposis-Associated Thyroid Cancer : A Clinical, Pathological, and Molecular Genetics Study Am. J. Pathol., January 1, 1999; 154(1): 127 - 135. [Abstract] [Full Text] [PDF]